These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6110626)

  • 21. Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine.
    Kett K; Aadland E; Berstad A
    Scand J Gastroenterol; 1980; 15(2):249-51. PubMed ID: 6104355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of gastric secretion in man by rioprostil, a new synthetic methyl prostaglandin E1.
    Demol P; Wingender W; Weihrauch TR; Graefe KH
    Arzneimittelforschung; 1985; 35(5):861-3. PubMed ID: 3927929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous pentagastrin can induce the illusion of 'tolerance' to a single dose of an H2-blocker in man.
    Nwokolo CU; Sawyerr A; Smith JT; Pounder RE
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():75-83. PubMed ID: 1983349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ranitidine on resting pressure and pentagastrin response of human lower esophageal sphincter.
    Denis P; Galmiche JP; Ducrotte P; Colin R; Pasquis P; Lefrancois R
    Dig Dis Sci; 1981 Nov; 26(11):999-1002. PubMed ID: 6117434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
    Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
    Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of esaprazole activity on basal gastric secretion and on pentagastrin-stimulated secretion in healthy volunteers.
    Erembourg L; Reggiani P; Tosi GP; Ferla G; Beinat L
    Int J Clin Pharmacol Res; 1987; 7(2):95-100. PubMed ID: 3583500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of pentagastrin-stimulated and nocturnal gastric secretion by ranitidine. A new H2-receptor antagonist.
    Peden NR; Saunders JH; Wormsley KG
    Lancet; 1979 Mar; 1(8118):690-2. PubMed ID: 85934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secretion of total pepsin and pepsin 1 in healthy volunteers in response to pentagastrin and to insulin-induced hypoglycaemia.
    Roberts NB; Sheers R; Taylor WH
    Scand J Gastroenterol; 2007 May; 42(5):555-61. PubMed ID: 17454875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Action of mifentidine on the secretory response to sham feeding and pentagastrin and on serum gastrin in duodenal ulcer patients.
    Bianchi Porro G; Lazzaroni M; Imbimbo BP; Sangaletti O; Ghirardosi C; Daniotti S
    Eur J Clin Pharmacol; 1987; 32(6):555-8. PubMed ID: 2888658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ranitidine or nocloprost on the selected gastric juice components in the patients with the gastric ulcer.
    Skrodzka D; Gabryelewicz A
    Rocz Akad Med Bialymst; 1997; 42(1):257-66. PubMed ID: 9581490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of methylated prostaglandin E2 analogues given orally in the inhibition of gastric responses to pentagastrin and peptone meal in man.
    Konturek SJ; KwiecieĊ„ N; Swierczek J; Oleksy J; Sito E; Robert A
    Gastroenterology; 1976 May; 70(5 PT.1):683-7. PubMed ID: 770226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of ranitidine on gastric mucus, pepsin and hydrochloric acid secretion in patients with duodenal ulcer.
    Gabryelewicz A; Sarosiek J; Laszewicz W
    Acta Med Pol; 1981; 22(4):335-9. PubMed ID: 6128866
    [No Abstract]   [Full Text] [Related]  

  • 33. Gastric juice and analysis of basal and stimulated secretion following treatment with rice-bran oil.
    Lloris JM; Bolant B; Gimeno L; Cejalvo D; Gimeno LO; Calvo MA; Perkins I
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):245-8. PubMed ID: 1811286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ranitidine suppression of gastric hypersecretion resistant to cimetidine.
    Danilewitz M; Tim LO; Hirschowitz B
    N Engl J Med; 1982 Jan; 306(1):20-2. PubMed ID: 6118836
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of sham feeding on gastric acid secretion in healthy subjects and duodenal ulcer patients: evidence for increased basal vagal tone in some ulcer patients.
    Feldman M; Richardson CT; Fordtran JS
    Gastroenterology; 1980 Nov; 79(5 Pt 1):796-800. PubMed ID: 7419002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin.
    Hammond JB; Offen WW
    Am J Gastroenterol; 1988 Jan; 83(1):32-6. PubMed ID: 2892392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of gastric secretion by a new H2-antagonist, YM-11170 in healthy subjects.
    Miwa M; Tani N; Miwa T
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):214-7. PubMed ID: 6325352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a histamine H2-receptor antagonist, famotidine, on gastric secretion in healthy subjects.
    Fukuda Y; Ikezoe I; Okabayashi M; Ohama I; Shimoyama T
    Clin Ther; 1987; 9(5):528-35. PubMed ID: 2889528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apparent and intrinsic sensitivity to pentagastrin of acid and pepsin secretion in peptic ulcer.
    Hirschowitz BI
    Gastroenterology; 1984 May; 86(5 Pt 1):843-51. PubMed ID: 6423436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged influence of a meal on the effect of ranitidine.
    Frislid K; Berstad A
    Scand J Gastroenterol; 1984 May; 19(3):429-32. PubMed ID: 6330872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.